New High Of Day: Nasdaq Low Float Profile (NMTC) Keeps Pushing Vertical, Demands Immediate Attention
NMTC keeps chugging along this morning.
Hitting a new high of day of $1.84, keeps inching towards the $2.00 level this morning.
Could we see a push to that level ahead of this week's Q3 financials announcement?
Remember, NMTC is trading above 3 key lines of potential support in its 50-Day Simple Moving Average, 200-Day Simple Moving Average, and its 13-Day Exponential Moving Average.
If those lines continue to strengthen with potential support, they could act as building blocks for NMTC to return to previous highs.
And with that news coming this week, now may be the best time to have NMTC at the top of your watch-list.
Read my initial NMTC report below now and get this Nasdaq profile pulled up quickly.
Time is ticking so let's not waste a second...
AVCO was brought to your attention after it closed Wednesday's session at $.645.
When Thursday's session came around, it went on an absolute tear running to a 4+ month high of $.8050.
With that run, AVCO became my latest short term stud running approximately 24% in the blink of an eye.
AVCO has now become one of my recent Nasdaq alert breakout champs over the past few months.
In fact, I'm not sure if we've missed recently as we've seen runaway Nasdaq Market rockers accounting for moves of:
and 18% in the intraday or short term.
Take a deep breath. Here's where things get interesting.
Seeing how hot that healthcare profile came out, I decided to stick to the same industry as AVCO for this new breakout idea.
Seeing how hot that healthcare profile came out, I decided to stick to the same industry for this new breakout idea.
Let me ask, what do you know about the future $13.6Bn neurostimulation devices market?
If it's not much, don't worry. All you need to soak in is the sheer size of this potential market by 2027 and let me fill in the details.
I've uncovered a company that is forwarding their game-changing tech to become an industry disruptor, but for now has flown well under Wall Street's radar.
With bullish technical indicators, an explosive chart history, huge August news, and a low float, it may be no better time than now to get this Nasdaq profile on your screen as it recently pushed above now key support lines including its:
- 50-Day Simple Moving Average (SMA)
- 13-Day Exponential Moving Average (EMA)
And if potential resistance breaks down at the 200-Day SMA level, which this profile has been battling mightily, all bets could be off on the vertical chart march this breakout idea could make.
Ready for the goods? Here it is:
*NeuroOne Medical Technologies Corporation (NMTC)*
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders that may improve patient outcomes and reduce procedural costs.
And right now, NMTC has 5 potential driver indicators to immerse yourself in:
No. 1 - Low Float Volatility Could Grab Hold
No. 2 - Accelerated Milestone Payment Accomplishes Multiple Objectives (Huge News)
No. 3 - Triggered Technicals Could Signal A Near Term Vertical Chart Move
No. 4 - Another Game-Changing Milestone With First Evo sEEG Electrode Clinical Case
No. 5 - A Chart History Of Explosive Short Term Runs
But more on those in a second...
Evo® Cortical Electrode
Cortical or subdural electrodes are used in electrocorticography (ECoG) or intracranial electroencephalography (iEEG) surgeries to monitor, record and stimulate the surface of the brain for up to 30 days. The company's Evo cortical electrode portfolio consists of various contact configurations of strip and grid electrodes. (Rx only)